License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: November 12, 2023
Last Modified: November 12, 2023
Protocol Integer ID: 90813
Abstract
CRISPR nuclease (CRISPRn) genome editing
LentiCRISPRv2 plasmid (RRID:Addgene_52961) was used for α-syn genome editing. All sgRNAs
were designed using CRISPick (https://portals.broadinstitute.org/gppx/crispick/public) and examined for genome-wide sequence specificityusing the National Center for Biotechnology Information’s (NCBI) Basic Local Alignment Search Tool NCBI BLAST
(RRID:SCR_004870)( http://blast.ncbi.nlm.nih.gov/Blast.cgi). The sgRNAs (Control 5’
GACGGAGGCTAAGCGTCGCAA3’ and α-syn CRISPRn 5’ GGTTCATGAAAGGACTTTCAA3’) were
cloned as described previously
CITATION
Shalem, O., Sanjana, N.E., Hartenian, E., Shi, X., Scott, D.A., Mikkelsen, T.S., Heckl, D., Ebert, B.L., Root, D.E., Doench, J.G., and Zhang, F. (2014). (2013). Genome-scale CRISPR-Cas9 knockout screening in human cells. Science.
To validate the sgRNAs constructs, DIV-3 hippocampal
primary neurons were infected with lentiviruses per 6hrs (MOI=5). Transduced
neurons were cultured to maturity (DIV17-DIV21) and then lysate for western
blotting analysis and genomic analysis.
Citations
Step 1
Shalem, O., Sanjana, N.E., Hartenian, E., Shi, X., Scott, D.A., Mikkelsen, T.S., Heckl, D., Ebert, B.L., Root, D.E., Doench, J.G., and Zhang, F. (2014).. Genome-scale CRISPR-Cas9 knockout screening in human cells